Log in or Sign up for Free to view tailored content for your specialty!
Leukemia News
Value of MRI, lumbar puncture questioned for immune cell-associated neurotoxicity syndrome
MRIs and lumbar punctures may not provide enough therapeutic value to be standard-of-care diagnostic tests in patients suffering neurologic symptoms following chimeric antigen receptor T-cell therapy.
National Comprehensive Cancer Network appoints board of directors chair, vice chair
Matt Kalaycio, MD, FACP, has been elected chair of National Comprehensive Cancer Network’s board of directors.
Combining genomics, drug sensitivity testing could be ‘invaluable’ cancer treatment tool
An innovative combination of drug sensitivity testing and genomics helped identify therapeutic options for children with relapsed or refractory solid or hematologic malignancies, according to results published in Nature Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
Parents of children with cancer more often seek help for anxiety, depression
Parents of children with cancer made mental health visits, including those for anxiety and depression, significantly more often than other parents, according to results published in JAMA Network Open.
Longer exclusive breastfeeding may lower hematologic cancer risk for children
Exclusive breastfeeding for at least 3 months was associated with reduced childhood hematologic cancer risk vs. shorter breastfeeding durations, according to cohort study results published in JAMA Network Open.
Elderly experience ‘impressive improvement’ in survival after stem cell transplant
Among elderly patients with acute myeloid leukemia, survival outcomes for those who received an allogenic stem cell transplant have improved significantly over the past 2 decades, according to data published in Clinical Cancer Research.
‘Wake-up call’: Cardiovascular toxicity a concern for patients receiving bispecifics
More than 20% of reported cases of adverse events following bispecific T-cell engager therapies involved a cardiovascular event, findings reported in Journal for ImmunoTherapy of Cancer showed.
Most U.S. cancer trials conducted in more affluent, less diverse areas
Most of the major cancer clinical trial centers in the U.S. are located near more affluent and white populations compared with the national average, according to results published in JAMA Oncology.
FDA grants accelerated approval to Iclusig for Philadelphia chromosome-positive ALL
The FDA granted accelerated approval to ponatinib with chemotherapy for the treatment of adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia, according to a press release.
Dana-Farber appoints new head for drug discovery and research
Scott A. Armstrong, MD, PhD, has been named senior vice president for drug discovery and chief research strategy officer at Dana-Farber Cancer Institute, according to a press release.
-
Headline News
E-cigarette use could raise heart failure risk up to 19%
April 17, 20242 min read -
Headline News
New data ‘offer some hope’ that checkpoint inhibitors may be safe for pregnant women
April 18, 20243 min read -
Headline News
Shorter hospital stays possible for children with pneumonia
April 17, 20243 min read
-
Headline News
E-cigarette use could raise heart failure risk up to 19%
April 17, 20242 min read -
Headline News
New data ‘offer some hope’ that checkpoint inhibitors may be safe for pregnant women
April 18, 20243 min read -
Headline News
Shorter hospital stays possible for children with pneumonia
April 17, 20243 min read